HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 05, 2025 (GLOBE…
More Than a Symposium: IOF Builds Momentum Toward the Future of Orthodontics
HONG KONG, June 03, 2025 (GLOBE NEWSWIRE) -- The International Orthodontics Foundation…
Tianfu Rapoil Shines at Hong Kong Hometown Market Carnival
HONG KONG, June 2, 2025 /PRNewswire/ -- This is a report from Xinhuanet:…
From Declaration to Action: Advancing Global Graft Fight under IAACA Steer
HONG KONG, May 31, 2025 /PRNewswire/ -- In May last year, the…
 
  					 
  							 
		 
		